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Abstract
Purpose Exercise echocardiography can assess the dynamic
component of mitral valve (MV) disease and may therefore
be helpful for the clinical decision-making by the heart team.
The purpose of this study is to determine the role of exercise
echocardiography in the management of disproportionately
symptomatic or otherwise atypical patients with mitral re-
gurgitation (MR) and stenosis (MS) in clinical practice.
Methods Data of 14 MR and 14 MS patients, including
echocardiograms at rest, were presented retrospectively to an
experienced heart team to determine treatment strategy. Sub-
sequently, exercise echo data were provided whereupon once
again the treatment strategy was determined. This resulted in:
value of exercise echo by means of 1) alteration or 2) confir-
mation of treatment strategy or 3) no additional value.
Results During exercise the echocardiographic severity of MV
disease increased in 9 (64 %) MR and 8 (57 %) MS patients.
Based upon alteration or confirmation of the treatment strategy,
the value of exercise echocardiography in the management of
MR and MS was 86 % and 57 %, respectively.
Conclusion This study showed that physical exercise echo
can have an important role in the clinical decision-making of
challenging patients with MV disease. Exercise echocardi-
ography had additional value to the treatment strategy in
71 % of these patients.
Keywords Exercise echocardiography . Physical exercise
echocardiography .Mitral valve disease . Mitral
regurgitation . Mitral stenosis . Clinical practice
Introduction
Mitral valve (MV) disease is a dynamic entity. Consequently,
patients can present as being asymptomatic or disproportion-
ately symptomatic in relation to the degree of severity of
their valve disease on the resting echo [1]. Management of
MV disease can therefore be challenging.
Exercise echocardiography
Echocardiography has been the most important and cost-
effective diagnostic imaging tool in clinical cardiology for
more than 30 years [2]. Rest echocardiography is nowadays
recommended in the diagnostic work-up of MV disease [3,
4] and has also shown to be of additional value in other valve
diseases [5]. Further echocardiographic development has
created new opportunities among which stress echocardiog-
raphy, performed by exercise or dobutamine. Exercise echo
is already widely accepted as an important diagnostic and
prognostic tool in the assessment of coronary artery disease
[1]. Exercise echocardiography is now also increasingly
being performed in the evaluation of MV disease and has a
place in the current European Society of Cardiology (ESC)
guidelines. Compared with dobutamine stress echo, the main
advantage of exercise echo is the direct evaluation of symp-
toms, exercise capacity and haemodynamic consequences of
MV disease. In mitral stenosis (MS), dobutamine stress
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echo is an alternative when physical exercise cannot be
performed (except for the evaluation of pulmonary
pressure) [6]. However, in mitral regurgitation (MR) it is
not useful due to its reduction in afterload and beneficial
effect on the MR [6, 7].
As exercise echocardiography can assess the dynamic
component of MR or MS, it may be helpful for clinical
decision-making.
Exercise echo in mitral regurgitation
MR is the second most frequent valve disease in Western
countries after aortic stenosis [8]. It can be classified as
organic or functional. Two-dimensional (2D) echocardiog-
raphy is the recommended method to confirm MR and must
include an assessment of severity, mechanism, reparability
and clinical consequences [3].
Exercise echocardiography is useful in experienced hands to
quantify exercise-induced changes in organic MR, systolic pul-
monary artery pressure (SPAP) and LV function [3]. The influ-
ence of exercise echo testing is evidenced by the ESC recom-
mendations: surgerymay be considered in asymptomatic patients
with severe organic MR, preserved LV function and SPAP
≥60 mmHg during exercise (class IIb, level of evidence C) [3].
However, a prospective trial to clarify the best treatment option in
these patients started in 2013 (Dutch AMR trial) [9].
In patients with moderate functional MR, development of
exercise-induced dyspnoea and increased MR severity, asso-
ciated with pulmonary hypertension, are further incentives to
indicate surgery (class IIa, level of evidence C) [3]. Never-
theless due to the low level of evidence, the exact value of
exercise echo in the management of MR remains unclear.
Exercise echo in mitral stenosis
With the reduction in rheumatic fever, MS is now less frequent-
ly seen in industrialised countries. However, MS results in
significant morbidity and mortality rates worldwide. Echocar-
diography is the main diagnostic method to assess severity,
consequences and the extent of anatomic lesions.MS prognosis
dramatically worsens with the development of symptoms [10].
Following the ESC guidelines, exercise testing is indicated in
asymptomatic patients or patients with symptoms equivocal or
discordant with the MS severity [3]. When analysing exercise-
induced changes in symptoms, SPAP and valve gradients may
provide extra information [3, 11]. Moreover, following the
American College of Cardiology/American Heart Association
(ACC/AHA) guidelines, further (invasive) intervention may be
considered in (even mild) symptomatic patients, with a signif-
icant increase in SPAP >60 mmHg or a rise in valve gradient
to >15 mmHg during exercise (class IIB, level of evidence C)
[4]. Furthermore percutaneous mitral balloon valvotomy is
indicated in asymptomatic patients with moderate to severe
MS and favourable characteristics, who reach an SPAP
>50 mmHg at rest or >60 mmHg during exercise (in the
absence of a left atrium thrombus or moderate to severe MR)
(class I, level of evidence C) [4].
Exercise echocardiography is now increasingly being
performed according to the guidelines and beyond: i.e. in
disproportionately symptomatic patients in relation to their
MV disease severity. The present study analysed the role of
physical exercise echocardiography for the evaluation and
management of disproportionately symptomatic or other-
wise atypical patients with MV disease.
Materials and methods
Study population
We retrospectively evaluated 28 resting and corresponding exer-
cise echocardiograms performed for the evaluation of MV dis-
ease in the University Medical Center of Utrecht (2009–2011).
Expert panel
Patient records were reviewed by an experienced heart team
consisting of a cardiologist and cardiothoracic surgeon. The
expert panel was provided with all available patient data
including resting echocardiogram, whereupon they deter-
mined if intervention should be considered. Subsequently,
exercise echo data were provided after which the expert
panel once more decided if they would perform an interven-
tion or watchful waiting strategy. Based on the preferred
treatment strategies, depending on resting and exercise echo
data respectively, three different outcomes were scored: val-
ue of exercise echo by means of either 1) change or 2)
confirmation of the treatment strategy or 3) no additional
value. Finally a change and/or confirmation determined the
true additional value of exercise echocardiography (Fig. 1).
Exercise echo protocol
The exercise protocol was tailored to the capacity of the
patient. Hence, 16 patients underwent exercise testing on a
semi-supine bicycle (Fig. 2). In 12 patients alternative exer-
cise testing was done, using a stepper or by performing knee
bends. ECG and blood pressure (non-invasively) were mea-
sured before, every 3 min during and after exercise. Symp-
toms were continuously monitored. An adjusted protocol
was used starting with a mean resistance of 30 (±12) Watts,
which the physician manually increased by 10–25 Watts
every 2–3 min. Exercise testing was performed until >85 %
of the age-predicted maximal heart rate was reached or when
exhaustion or recognisable symptoms occurred.
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All patients underwent 2D transthoracic echocardiography
(TTE) during physical exercise on a semi-supine bicycle or in
the left lateral decubitus position directly after exercise. MR
mechanism and severity were classified both on colour Dopp-
ler and according to the recommendations for quality echo-
cardiography laboratory operations [12]. Measurement of tri-
cuspid regurgitation (TR) jet velocity was performed in the
parasternal short-axis or in the apical four-chamber view,
resulting in right ventricular systolic pressure (RVSP) by
adding the right atrial pressure (RAP) to the peak TR gradient.
The mean transmitral gradient was measured by tracing the
area-under-the-curve of the mitral E and Awaves obtained by
continuous Doppler in the apical views.
Examinations were performed with the Philips 5500 or
Philips IE33 (PhilipsMedical Systems, Andover, Massachu-
setts, USA) echo machines. All datasets were archived on the
hospital server as video loops and freeze frames in a digital





The MR group consisted of 14 patients (7 organic and 7
functional MR). Mean age was 66 (31–78) years. All patients
were symptomatic. The LV function was normal in 11 pa-
tients (79 %).
MR severity at rest was classified at baseline: 1 severe, 4
moderate and 7 mild. Two patients had clinical suspicion of
MR but no regurgitation on resting images (Tables 1 and 2).
Exercise echo
The mean heart rate during exercise was 131 (80–160) beats
per minute (bpm). Nine patients (64 %) reached >85 % of the
age-predicted maximal heart rate (mean 145±12 bpm). In
43 % β-adrenergic blocking medication was used. Severity
of MR during exercise increased in 9/14 patients (64 %).
During exercise, 4 patients had severe MR. Exercise RVSP
was ≥60 mmHg in 5 (36 %) subjects, of whom 3 (60 %) were
diagnosed with severe MR during exercise (Table 2). In 10
patients (71 %) stress RVSP was higher compared with the
resting value (5 patients ≥60 mmHg), and in 4 subjects a
change in RVSP could not be determined. Figure 3a shows
the increase in mean RVSP from 29.9±4.5 mmHg at rest to
54.2±15.8 mmHg during exercise.
Clinical management
Based on the judgment of the expert panel an intervention
was indicated in 5 MR patients (80 % new indication); 4
patients in this group had severe MR during exercise (of
whom 1 already had severe MR at rest) and in 4 patients
exercise RVSP was ≥60 mmHg (Table 2). In 1 patient with
RVSP ≥60 mmHg during exercise but at the same time
moderate MR, an intervention was not recommended.
Figure 4a demonstrates a change in recommended treat-
ment strategy for MR patients in 29 % and confirmation in
57 %. The value of physical exercise echocardiography in
the management of MR was demonstrated in 86 %.
Mitral stenosis
Patient characteristics
The MS group consisted of 14 patients of whom 7 (50 %)
had organic disease and 7 (50 %) had MS after mitral valve
repair (MVR). Mean age was 56 (29–83) years and 86 %
were symptomatic. LV function was normal in 93 %. Sever-
ity of MS at rest was classified at baseline: 1 severe, 11
moderate and 2 mild (Tables 1 and 3).
Fig. 1 Study methods: the
decision flowchart per patient,
used by the expert panel (1 to 5)
Fig. 2 Exercise echocardiography on a semi-supine bicycle in the
University Medical Center of Utrecht
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Exercise echo
During exercise echocardiography the mean heart rate was
115 (80–150) bpm. Four patients (29 %) achieved >85 % of
the age-predicted maximal heart rate (mean 143±9 bpm). Of
these patients 71 % used β-adrenergic blocking medica-
tion. MS severity during exercise increased in 8/14 pa-
tients (57 %). Seven patients had severe MS during
exercise. Exercise-induced RVSP was ≥60 mmHg in 4
(29 %) of the MS patients. Three of them (75 %) were
diagnosed with severe MS during exercise. Stress mean
gradient values increased to >15 mmHg in 7 (50 %)
patients. All were diagnosed with severe MS during exercise
(Table 3).
RVSP increased in 11 patients (79 %) during exercise (4
patients ≥60 mmHg), whereas in 2 cases RVSP could not be
determined. One patient showed a slight decrease in RVSP.
However, with severe MS and exercise-induced mean gradi-
ent >15 mmHg, intervention was still recommended in this
patient by the expert panel.
Figure 3b and c show a rise in mean RVSP and mean
gradient during exercise from 34.9±9.0 mmHg to
52.1±17.8 mmHg and from 6.9±2.4 mmHg to
15.9±7.3 mmHg, respectively.
Clinical management
The expert panel recommended an intervention in every
patient who developed severe MS during exercise (7). For
6 patients this indication was new (Table 3). In all 7 subjects
exercise-induced mean gradient was >15 mmHg and 3
(43 %) had an RVSP ≥60mmHg. Of the patients with exercise
RVSP ≥60 mmHg, 75 % received an indication for surgery.
Figure 4b shows a change in recommended treatment
strategy in 43 % of all MS patients and confirmation in
14 %. The value of physical exercise echocardiography in
the management of MS was seen in 57 %.
Discussion
The present study is remarkable for its objective to define the
clinical value of exercise echocardiography for decision-
making in challenging patients with MS or MR who cannot
easily be classified by the guidelines.
As clearly described by Van de Heyning et al. [13],
several articles have already pointed out the increasing evi-
dence for exercise echo in determining dynamic changes in
MV disease and to identify high-risk patients who may
benefit from (early) intervention. In addition, our study
showed that exercise echocardiography was of additional
value in the clinical decision-making in 20/28 (71 %) of all
patients, demonstrating 10 patients with a change and 10
patients with confirmation of treatment strategy.
Exercise-induced changes in MV disease severity
Data supporting exercise-induced changes in echocardio-
graphic parameters to quantify MR are limited [3, 11].
Only an exercise-induced increase of the effective regur-
gitant orifice area (EROA) by ≥13 mm has shown to be
associated with a significant increase in relative risk of
death and hospitalisation for cardiac decompensation in
functional MR [14]. Unfortunately EROA is difficult to mea-
sure, especially during exercise. Furthermore, exercise echo-
cardiography has only shown to be useful in observing symp-
toms caused by an increase in MR severity in symptomatic
patients with mild rheumatic MR at rest [15].
In our study MS severity was mainly based on the mean
gradient value. Determining MS severity by mean gradient
using exercise echocardiography has proven to be feasible
and well correlated with invasive measurements [16–18].
Previous studies also demonstrated marked elevations in
mean gradient after peak exercise in patients with predomi-
nantly MS [19–23]. Further (invasive) intervention may
therefore be considered in (even mild) symptomatic patients
with a significant increase in valve gradient to >15 mmHg
during exercise (class IIB, level of evidence C) [4].
Table 1 Baseline characteristics
Baseline MR MS
Patient characteristics
Study group 14 14
Age (range) 66 (31–78) 56 (29–83)
Gender:
Male (%) 50 29












Semi-supine bicycle 10 6
Alternative exercise testb 4 8
MR mitral regurgitation, MS mitral stenosis
a According to the ESC guidelines: left ventricular ejection fraction of
≤60 % or left ventricular end systolic dimension of ≥45 mm [4]
b Using a stepper or performing knee bends
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As a result, in all 7 MS subjects with an exercise-induced
mean gradient >15 mmHg, our expert panel recommended
an intervention. However, the proposed cut-off value by the
guidelines (>15 mmHg) is arbitrary, consensus driven and
not supported by solid evidence.
Exercise-induced changes in pulmonary pressures
Echocardiography has been validated as the principal tool for
measuring pulmonary pressures in daily practice, although
discrepancy exists on the correlation between echocardio-
graphic findings and invasive measurements [24]. Guidelines
regarding MS urge to consider further intervention in symp-
tomatic patients with significant elevation of SPAP
(>60 mmHg) during exercise [19, 25, 26]. Furthermore,
marked pulmonary hypertension (SPAP >50 mmHg at rest
or >60 mmHg during exercise) is associated with a poor
prognosis in patients with LV dysfunction [27]. Despite a
low level of evidence, echocardiographic measurement of an
exercise-induced SPAP ≥60 mmHg has therefore also been
suggested as cut-off value for considering MVR in asymp-
tomatic patients with severe organic MR and preserved LV
Fig. 3 Right ventricular systolic pressure (RVSP) values in patients
with mitral regurgitation (a) and mitral stenosis (b) and mean gradient
values in mitral stenosis (c) during rest and exercise echocardiography
Fig. 4 The value of exercise echocardiography in mitral regurgitation
(a) and mitral stenosis (b)
























































































































































































































































































































































































































































































































































































































































































































































































































































































Neth Heart J (2013) 21:487–496 493
function [3]. Moreover, Lebrun et al. showed that SPAP
values were greatest in patients with marked dynamic MR,
and well correlated with increases in regurgitant volume
(PISA method) [28].
However, no reference values exist for physiological
exercise-induced changes in SPAP. Also other factors than
MV disease can play a role in the dynamic changes during
exercise, e.g. alterations of pulmonary resistance and neuro-
hormonal activation [28].
In absence of right-sided flow obstruction, SPAP and
RVSP values were equal in this study. Although stress RVSP
peak values of 35–45 mmHg are regarded as physiological
[29–31] in (young, male) endurance athletes and older pa-
tients (≥60 years), peak-exercise values of >60 mmHg have
been reported [32, 33]. The prognostic significance of this
marked increase has not been defined. It has been advocated
to integrate age and level of exercise with the exercise-
induced SPAP response to determine abnormal elevation of
pulmonary pressures [24, 29, 33]. In our study a stress SPAP
of ≥60 mmHg in patients with less than maximal workload
was classified as pathological.
The expert panel’s decision was influenced by the RVSP
measurement during exercise in 13 (46 %) of all patients. In
15 patients management was determined based on other
criteria, e.g. an increase in mean gradient (an intervention
was recommended in all MS patients with mean gradient
>15 mmHg).
Value of exercise echocardiography
For optimal exercise testing, a heart rate of >85 % of the age-
predicted maximal heart rate was obligatory. In 64 % of the
MR patients this criteria was achieved, versus only 29 % of
the MS patients. Moreover, the total mean heart rate
appeared to be lower in MS compared with MR (115 versus
131 bpm). Both remarks can be explained by the use of more
β-adrenergic blocking agents in the MS population com-
pared with MR patients (71 % versus 43 %).
Although exercise echocardiography is only recommend-
ed in asymptomatic patients with severe MR [3], in this study
we analysed symptomatic MR patients. Apparently, in daily
clinical practice exercise echocardiography is more and more
supposed to be of additional value in disproportionately
symptomatic patients. Furthermore, the additional value in
12 symptomatic (86 %) and 2 asymptomatic (14 %) MS
patients certainly fits within the earlier described guideline
recommendations for exercise echocardiography in both
asymptomatic and symptomatic MS [3, 4].
Limitations
This study was retrospective with its inherent limitations.
The decision to perform an exercise echocardiography had
already been made by the physician, thus our patient popu-
lation is a selected one. Because patient numbers were rather
small, no subanalysis for specific MR or MS aetiologies
could be performed. We also did not focus on the exact
difference in LV function by measuring ejection fraction at
rest and during exercise, but in our patient cohort it appeared
to be less of importance. Finally, the expert panel judgment
did not account for the interaction between patient and
treating physician as this is not possible in this type of
research. This might ultimately have resulted in a different
treatment strategy by the expert panel compared with the
treating physician.
Only 2 patients were asymptomatic at rest. Evaluation of
symptomatic patients remains subjective and is solely based
on the patient’s history and cardiologist’s interpretation. Nev-
ertheless, being symptomatic is of utmost importance in the
recommended guidelines for MV surgery and therefore im-
portant in determining the best treatment strategy [3, 4]. Thus,
exercise echocardiography also serves as an important addi-
tional tool to unmask specific symptoms in atypical patients.
Concerning the technical limitations, evaluation of echo-
cardiographic examination is sometimes limited by a poor
imagingwindow, which is evenmore difficult during exercise.
Therefore considerable experience is needed to obtain good
quality echo studies. Moreover, patients may be unable to
exercise, or perform a submaximal test. Furthermore, while
exercise-related symptoms may sometimes be difficult to
interpret and remain subjective, additional haemodynamic
parameters during exercise are indispensable. However these
(noninvasive) measurements can be difficult to perform
during exercise, differ in accuracy and may not be fully
established.
Future prospective
A prospective trial is needed to confirm the value of exercise
echocardiography in the management of MV disease.
Subanalysis of various mechanisms is necessary since they
are based on different aetiologies and are diagnosed and
treated accordingly.
Avalidated and standardised exercise protocol is necessary
in order to compare exercise echo results. Exercise endpoints
should be determined at >85% of the age-predicted maximum
heart rate, or the occurrence of recognisable symptoms.
Furthermore, there may be an important role for real-time
three dimensional (3D) echocardiography as an alternative
for 2D exercise echocardiography [34].
Conclusion
Exercise echocardiography is an important tool to unravel dy-
namic changes andmonitor symptomatic responses occurring in
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MV disease during physical exercise. It can support the heart
team in determining the best treatment strategy in disproportion-
ately symptomatic or otherwise atypical patients, as seen in
71 % of our study patients. A prospective trial is needed to
support our findings by confirming the additional value of
exercise echocardiography in patients with MV disease and its
different aetiologies.
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